You have 9 free searches left this month | for more free features.

blinatumomab

Showing 1 - 25 of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)

Completed
  • Hematopoietic/Lymphoid Cancer
  • Richter's Transformation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Blinatumomab
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Apr 4, 2022

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Sep 25, 2022

Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

Completed
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Hematopoietic Cell Transplantation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 9, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Conventional therapy
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Soochow University
Sep 26, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

Recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +1 more
Jan 6, 2022

B-Precursor ALL Trial in Germany (Blinatumomab)

Recruiting
  • B-Precursor ALL
  • Blinatumomab
  • Frankfurt (Main), Hessen, Germany
  • +20 more
Aug 16, 2022

Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial (Blinatumomab)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Mixed Phenotype Acute Leukemia
  • Blinatumomab
  • (no location specified)
Apr 7, 2022

B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Alpha/Beta T-cell and B-cell depleted HCT
  • Blinatumomab
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Sep 12, 2021

ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

Active, not recruiting
  • ALL, Recurrent, Adult
  • Blinatumomab
  • Frankfurt (Main), Hessen, Germany
  • +21 more
Mar 16, 2022

ALL, Adult Trial in Belgium, Netherlands (Blinatumomab)

Active, not recruiting
  • ALL, Adult
  • Blinatumomab
  • Antwerpen, Belgium
  • +17 more
Dec 29, 2021

Non-Hodgkin Lymphoma Trial in Boston (Blinatumomab)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Blinatumomab
  • Boston, Massachusetts
    Massachusetts general Hospital
Jan 31, 2021

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Tampa, Florida
  • +2 more
Feb 14, 2022

Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)

Recruiting
  • Philadelphia-Negative ALL
  • High-Risk Cancer
  • Blinatumomab
  • Haifa, Israel
  • +3 more
May 6, 2021

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • +2 more
  • Duarte, California
  • +18 more
Jul 27, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Blinatumomab
  • Duarte, California
  • +21 more
Jan 4, 2022

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • (no location specified)
Dec 28, 2020

Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)

Withdrawn
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 30, 2021

Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel, Blinatumomab, Inotuzumab)

Withdrawn
  • Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • +2 more
  • (no location specified)
Jul 7, 2020

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Multiple Myeloma Trial in Philadelphia (Blinatumomab)

Terminated
  • Multiple Myeloma
  • Blinatumomab
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 5, 2020

B-Cell Non Hodgkin Lymphoma Trial in Worldwide (Blinatumomab)

Completed
  • B-Cell Non Hodgkin Lymphoma
  • Blinatumomab
  • Duarte, California
  • +30 more
Dec 18, 2020

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022